Regular Antibacterial Photodynamic Therapy on Oral Hygiene in Elderly Residents

NCT05853679 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2023-08-08

No results posted yet for this study

Summary

Around 40 people will participate in the study. The study participants will be recruited from service homes in the City of Helsinki. The subjects will be randomized into two groups. One of the groups will receive daily photodynamic Lumoral treatment for 2 months in a home care unit according to a separate instruction manual. At the beginning of the study, all subjects will receive an oral cleaning and will also be provided with electric toothbrushes. In addition, residents and care home personnel will be instructed on daily tooth cleaning.

During the study, all participants will undergo clinical measurements and an assessment of the oral inflammatory load. The samples will be stored for later analysis. In addition, residents or care home personnel answer questions about oral self-care. These measurements and examinations will be carried out at the start of the study and two months after the start of the study. After the end of the study, participants will continue to be treated according to their usual care and individual care plan.

Conditions

  • Dental Plaque
  • Pus Collection
  • Oral Disease
  • Dryness Oral
  • Tooth Decay

Interventions

DEVICE

Lumoral Treatment

The device will be used 5 to 7 times per week according to the manufacturer's instructions.

OTHER

Standard oral hygiene instructions according to the Finnish Dental Association

Participants will be instructed to clean their teeth twice per day by an electric toothbrush, an interdental brush, and flossing.

Sponsors & Collaborators

  • University of Helsinki

    collaborator OTHER
  • City of Helsinki

    collaborator OTHER
  • Koite Health Oy

    lead INDUSTRY

Principal Investigators

  • Timo Sorsa, Professor · University of Helsinki

  • Riitta Saarela · City of Helsinki

  • Tommi Pätilä · Helsinki University Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-04-18
Completion
2023-04-18

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05853679 on ClinicalTrials.gov